BUB1B and prostate cancer: Our data provide solid evidence that monoallelic BUB1B variants are sufficient to cause a large spectrum of subclinical progressive chromosomal instability that predisposes carriers to (prostate) cancer development, supporting the classification of the variants identified in this study as “likely pathogenic” and pinpointing BUB1B as a (pan)cancer predisposing gene.